ï»¿<!DOCTYPE html ><html><body><div>S-0520.1</div><hr style="margin-left:1.25in;margin-right:1.25in;height:1px;color:#333;" /><div style="font-weight:bold;text-align:center;">SENATE BILL 5326</div><hr style="margin-left:1.25in;margin-right:1.25in;height:1px;color:#333;" /><table style="width:622px;margin-top:0.1in;"><tr><td><div style="font-weight:bold;">State of Washington</div></td><td><div style="font-weight:bold;">69th Legislature</div></td><td><div style="font-weight:bold;">2025 Regular Session</div></td></tr></table><div style="margin-top:0.1in;"><span style="font-weight:bold;margin-right:0.25in;">By</span><!-- field: Sponsors -->Senators Cleveland, Muzzall, Chapman, Hasegawa, Krishnadasan, Nobles, Trudeau, and Valdez<!-- field: --></div><div style="margin-top:0.1in;"><span style="margin-right:0.25in;">Read first time 01/17/25.</span><span style="margin-right:0.25in;">Referred to Committee on Health &amp; Long-Term Care.</span></div><div style="text-indent:0.5in;margin-top:0.5in;"><!-- field: CaptionsTitles -->AN ACT Relating to accessing an emergency supply of insulin; and adding new sections to chapter  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=70.330'>70.330</a> RCW. <!-- field: --></div><div style="margin-top:0.25in;margin-bottom:0.25in;">BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:</div><div style="margin-top:0.25in;text-indent:0.5in;"><!-- field: BeginningSection --><span style="text-decoration:underline;">NEW SECTION.</span><span>Â Â </span><span style="font-weight:bold;padding-right:0.1in;">Sec. 1.  </span><span style="text-indent:0.5in;">The definitions in this section apply throughout sections 2 and 3 of this act unless the context clearly requires otherwise.</span><!-- field: --></div><div style="text-indent:0.5in;"><!-- field: Text -->(1) "Authority" means the health care authority.</div><div style="text-indent:0.5in;">(2) "Manufacturer" means a person, corporation, or other entity engaged in the manufacture of insulin that is self-administered on an outpatient basis and sold in or into Washington state.</div><div style="text-indent:0.5in;">(3) "Network pharmacy" means a pharmacy as defined in RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=18.64.011'>18.64.011</a> that is contracted with the prescription drug purchasing consortium established in RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=70.14.060'>70.14.060</a>.</div><!-- field: --><div style="margin-top:0.25in;text-indent:0.5in;"><!-- field: BeginningSection --><span style="text-decoration:underline;">NEW SECTION.</span><span>Â Â </span><span style="font-weight:bold;padding-right:0.1in;">Sec. 2.  </span><span style="text-indent:0.5in;">(1) The authority shall establish an emergency insulin program under the prescription drug purchasing consortium established in RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=70.14.060'>70.14.060</a> to allow eligible individuals to access one emergency 30-day supply of insulin within a 12-month period for a maximum out-of-pocket cost of $10 beginning January 1, 2026.</span><!-- field: --></div><div style="text-indent:0.5in;"><!-- field: Text -->(2) To be eligible to receive insulin under this section, an individual must:</div><div style="text-indent:0.5in;">(a) Be a resident of Washington;</div><div style="text-indent:0.5in;">(b) Not be enrolled in medical assistance or in prescription drug coverage that limits the total amount of cost sharing that the enrollee is required to pay for a 30-day supply of insulin, including copayments, deductibles, or coinsurance, to $35 or less, regardless of the type or amount of insulin prescribed;</div><div style="text-indent:0.5in;">(c) Have a valid prescription for insulin; and</div><div style="text-indent:0.5in;">(d) Have less than a seven-day supply of insulin available.</div><div style="text-indent:0.5in;">(3) The authority shall establish a process to permit an individual to attest to meeting the eligibility criteria in subsection (2) of this section.</div><div style="text-indent:0.5in;">(4)(a) An individual who attests to meeting eligibility criteria as required in subsection (3) of this section will be provided an electronic voucher to be utilized at a network pharmacy for the receipt of a 30-day supply of insulin under this section.</div><div style="text-indent:0.5in;">(b) A network pharmacy shall accept a voucher provided according to this subsection for purposes of dispensing a 30-day supply of insulin.</div><div style="text-indent:0.5in;">(5)(a) Upon dispensing the insulin the network pharmacy may collect a dispensing fee from the eligible individual of up to $10 to cover the pharmacy's costs of processing and dispensing the insulin.</div><div style="text-indent:0.5in;">(b) After a network pharmacy dispenses insulin to an eligible individual, it shall submit a claim for reimbursement to the consortium in a manner and form prescribed by the authority.</div><div style="text-indent:0.5in;">(6)(a) The consortium shall reimburse the network pharmacy for the cost of the dispensed insulin within 30 days of receiving the claim.</div><div style="text-indent:0.5in;">(b) The consortium shall, at least quarterly, invoice insulin manufacturers for the cost of the insulin the consortium reimbursed to pharmacies.</div><div style="text-indent:0.5in;">(c) A manufacturer shall remit payment to the consortium within 30 days of receiving an invoice under this subsection.</div><div style="text-indent:0.5in;">(7) The authority may assess a fine of up to $10,000 for each failure of a manufacturer to comply with the requirements of subsection (6)(c) of this section. The assessment of a fine under this subsection is subject to review under the administrative procedure act, chapter  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=34.05'>34.05</a> RCW. Fines collected under this section must be deposited into the state health care affordability account created in RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=43.71.130'>43.71.130</a>.</div><div style="text-indent:0.5in;">(8) The authority shall make available on its website, at the same location as information regarding the emergency insulin program established in this section, information regarding manufacturer patient assistance programs that allow patients to receive insulin at reduced or no cost.</div><!-- field: --><div style="margin-top:0.25in;text-indent:0.5in;"><!-- field: BeginningSection --><span style="text-decoration:underline;">NEW SECTION.</span><span>Â Â </span><span style="font-weight:bold;padding-right:0.1in;">Sec. 3.  </span><span style="text-indent:0.5in;">The authority shall adopt any rules necessary to implement this act.</span><!-- field: --></div><!-- field: --><div style="margin-top:0.25in;text-indent:0.5in;"><!-- field: BeginningSection --><span style="text-decoration:underline;">NEW SECTION.</span><span>Â Â </span><span style="font-weight:bold;padding-right:0.1in;">Sec. 4.  </span><span style="text-indent:0.5in;">Sections 1 through 3 of this act are each added to chapter  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=70.330'>70.330</a> RCW.</span><!-- field: --></div><!-- field: --><div style="margin-top:0.1in;font-weight:bold;text-align:center;">--- END ---</div></body></html>